Novartis Prevails In Bone Drug Trial In NC
A North Carolina federal jury found Wednesday that Novartis Pharmaceutical Corp.'s failure to provide an adequate warning regarding the use of its bone drugs Zometa and Aredia didn't proximately cause a...To view the full article, register now.
Already a subscriber? Click here to view full article